FDA will be holding an open public hearing regarding treatment of peripheral neuropathies
Many of Burke Harvey & Frankowski’s long term disability clients suffer from peripheral neoropathies. As a part of a public service, Burke Harvey and Frankowski wants the public to know that the FDA will be holding an open public hearing and workshop to further the understanding of the development of disease-modifying agents for the treatment of painful peripheral neuropathies. Comments for the open public hearing due by February 1, 2013. Written comments due by March 1, 2013.